Please Enable Cookies

www.laserfocusworld.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction

Uptake of Biogen's breakthrough Alzheimer's drug, Leqembi, appears to be picking up, with roughly $40 million in sales for the quarter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.